Both in Biotechnology
Vir Biotechnology vs ADMA Biologics
Over the past year VIR returned +96.4% and ADMA returned −28.0%; their daily moves had a correlation of 0.21.
VIR +96.4% ADMA −28.0%Growth of $1, one year, split-adjusted
| Metric | VIR | ADMA |
|---|---|---|
| Price | $11.00 | $11.06 |
| Market cap | $1.86B | $2.48B |
| Today | −2.65% | −3.07% |
| 1 month | −1.5% | +13.8% |
| 6 months | +8.1% | +7.3% |
| Year to date | +82.4% | −39.4% |
| 1 year | +85.5% | −27.6% |
| Revenue growth (YoY) | +19582.5% | +2.0% |
| Gross margin | 100.0% | 69.4% |
| Net margin | 33.5% | 30.4% |
| P/E (TTM) | — | 14.7× |
| Price / sales | 6.1× | 4.8× |
| Net cash | $532.7M | -$60.6M |
| Dividend yield | — | — |
| Volatility (60d) | 51.4% | 38.6% |
| Short % of float | 12.3% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).